Secretion of a single-gene-encoded immunoglobulin from myeloma cells.
|
journal
|
September 1993 |
Novel tumor target for antibody-based therapy of rhabdomyosarcoma and other pediatric solid tumors
|
journal
|
January 2000 |
Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
|
journal
|
March 2000 |
A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma
|
journal
|
July 1997 |
Improved Gene Transfer into Human Lymphocytes Using Retroviruses with the Gibbon Ape Leukemia Virus Envelope
|
journal
|
August 1996 |
SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
|
journal
|
January 1994 |
Desmoplastic Small Round Cell Tumor: II: An Ultrastructural and Immunohistochemical Study with Emphasis on New Immunohistochemical Markers
|
journal
|
January 1998 |
Gamma Camera Dual Imaging with a Somatostatin Receptor and Thymidine Kinase after Gene Transfer with a Bicistronic Adenovirus in Mice
|
journal
|
May 2002 |
GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma
|
journal
|
May 1989 |
Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23
|
journal
|
September 1986 |
Autologous stem cell transplantation for solid tumors in children
|
journal
|
January 1997 |
Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
|
journal
|
December 1998 |
Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
|
journal
|
July 1997 |
Expression of Somatostatin Receptor Subtype 2 mRNA in Human Lymphoid Cells
|
journal
|
October 1997 |
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
|
journal
|
September 1979 |
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
|
journal
|
September 1998 |
Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays
|
journal
|
August 1989 |
Rapid selection of antigen-specific T lymphocytes by retroviral transduction
|
journal
|
July 2000 |
Ga-66 labeled somatostatin analogue DOTA-DPhe 1 -Tyr 3 -octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
|
journal
|
February 2002 |
Continuous cultures of fused cells secreting antibody of predefined specificity
|
journal
|
August 1975 |
Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy
|
journal
|
July 1997 |
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
|
journal
|
June 1997 |
Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
|
journal
|
May 1996 |
A Monte Carlo approach to patient-specific dosimetry
|
journal
|
September 1996 |
Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
|
journal
|
May 1994 |
Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene
|
journal
|
August 1994 |
High-Efficiency Gene Transfer into Normal and Adenosine Deaminase-Deficient T Lymphocytes Is Mediated by Transduction on Recombinant Fibronectin Fragments
|
journal
|
January 1998 |
Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
|
journal
|
January 1984 |
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
|
journal
|
July 1994 |
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
|
journal
|
February 1989 |
MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
|
journal
|
July 2009 |
Impact of chimeric immune receptor extracellular protein domains on T cell function
|
journal
|
March 1999 |
Tyrosine kinase chimeras for antigen-selective T-body therapy
|
journal
|
April 1998 |
Barriers to Drug Delivery in Solid Tumors
|
journal
|
July 1994 |
Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
|
journal
|
September 2000 |
Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction
|
journal
|
January 1999 |
Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and Tumors
|
journal
|
January 1988 |
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
|
journal
|
June 1992 |
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
|
journal
|
June 1991 |
Common Musculoskeletal Tumors of Childhood and Adolescence
|
journal
|
July 1999 |
Radioimmunotherapy with alpha-emitting nuclides
|
journal
|
September 1998 |
Rhabdomyosarcoma
|
journal
|
August 1997 |
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
|
journal
|
January 1994 |
Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
|
journal
|
March 1999 |
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor
|
journal
|
July 1990 |
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
|
journal
|
June 1998 |
Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
|
journal
|
March 1995 |
Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation
|
journal
|
July 1993 |
Mammalian expression of single chain variable region fragments dimerized by Fc regions
|
journal
|
January 1995 |
Production of a Single-Chain Fragment of the Murine Anti-Idiotypic Antibody ACA125 as Phage-Displayed and Soluble Antibody by Recombinant Phage Antibody Technique
|
journal
|
February 1997 |
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
|
journal
|
July 1992 |
Single‐chain Fvs
|
journal
|
January 1995 |
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.
|
journal
|
September 1998 |
The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature
|
journal
|
March 1990 |
Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas
|
journal
|
November 1993 |
Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
|
journal
|
January 1995 |
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|
journal
|
October 1995 |
Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma
|
journal
|
January 2001 |
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
|
journal
|
March 2003 |
Specific Lysis of Melanoma Cells by Receptor Grafted T Cells is Enhanced by Anti-Idiotypic Monoclonal Antibodies Directed to the scFv Domain of the Receptor
|
journal
|
May 1999 |
Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries.
|
journal
|
July 1995 |
Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
|
journal
|
October 1993 |
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
|
journal
|
March 1992 |
Anti-Tumor Activity of Human T Cells Expressing the CC49-zeta Chimeric Immune Receptor
|
journal
|
January 1999 |
CANCER MODELS: Systems for Identifying New Drugs Are Often Faulty
|
journal
|
November 1997 |
Anti-Idiotypic Antibody as the Surrogate Antigen for Cloning scFv and its Fusion Proteins
|
journal
|
December 2002 |
Single-chain antigen-binding proteins
|
journal
|
October 1988 |
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
|
journal
|
April 1987 |
Human Glioma-Specific Antigens Detected by Monoclonal Antibodies
|
journal
|
January 1992 |
Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
|
journal
|
February 1997 |
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes
|
journal
|
May 2004 |
Single-chain antibody streptavidin fusions: Tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen
|
journal
|
September 1995 |
Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
|
journal
|
March 1996 |
Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor
|
journal
|
October 2002 |
Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC)
|
journal
|
March 2000 |
Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
|
journal
|
January 1999 |
Autologous stem cell transplantation for high-risk pediatric solid tumors
|
journal
|
September 1999 |
An optimized method for cell-based phage display panning
|
journal
|
March 1997 |
Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies
|
journal
|
March 1999 |
Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
|
journal
|
June 2001 |
A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.
|
journal
|
September 1994 |
Immunological Responses to the Tumor-Associated Antigen CA15 in Patients with Advanced Ovarian Cancer Induced by the Murine Monoclonal Anti-idiotype Vaccine ACA125
|
journal
|
February 1997 |
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report
|
journal
|
January 1995 |
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
|
journal
|
February 1996 |
Radionuclide photon dose kernels for internal emitter dosimetry
|
journal
|
May 1996 |
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
|
journal
|
January 1995 |
A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody.
|
journal
|
July 1986 |
Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
|
journal
|
October 1999 |
Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors
|
journal
|
October 1999 |
Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR: Monitoring of MRD by Real-time Quantitation
|
journal
|
August 1998 |
T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
|
journal
|
February 1996 |
CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: Implications for cellular immunotherapy of CD20+ malignancy
|
journal
|
August 1998 |
Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
|
journal
|
August 1996 |
Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood
|
journal
|
January 1994 |
Immunomagnetic Purging of Ewing’s Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction
|
journal
|
August 2001 |
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing’s sarcoma and alveolar rhabdomyosarcoma
|
journal
|
September 1999 |
Diganglioside GD2 and Antigen 8H9: Potential Targets for Antibody-Based Immunotherapy against Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
|
journal
|
April 1999 |
Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
|
journal
|
August 1993 |
Expression of HER2/ erb B-2 Correlates With Survival in Osteosarcoma
|
journal
|
September 1999 |
New monoclonal antibodies specific for human sarcomas
|
journal
|
July 1986 |
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
|
journal
|
June 1997 |
Effect of glycosylation on antibody function: implications for genetic engineering
|
journal
|
January 1997 |
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
|
journal
|
October 1997 |
High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors
|
journal
|
December 1997 |
Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes
|
journal
|
January 2001 |
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|
journal
|
September 1987 |
Immunocytokines: A Promising Approach to Cancer Immunotherapy
|
journal
|
December 1998 |
Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition
|
journal
|
June 1997 |
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
|
journal
|
March 1994 |
In Vitro and in Vivo Cytotoxic Activities of Recombinant Immunotoxin 8H9(Fv)-PE38 against Breast Cancer, Osteosarcoma, and Neuroblastoma
|
journal
|
February 2004 |
Man-made antibodies
|
journal
|
January 1991 |
Monoclonal antibody against ependymoma-derived cell line
|
journal
|
January 1992 |
Anti-Idiotypic Antibody Facilitates scFv Chimeric Immune Receptor Gene Transduction and Clonal Expansion of Human Lymphocytes for Tumor Therapy
|
journal
|
August 2003 |
Reassessment of patient response to monoclonal antibody 3F8.
|
journal
|
April 1992 |
Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region
|
journal
|
July 1999 |
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
|
journal
|
November 1979 |
Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
|
journal
|
October 1996 |
Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts
|
journal
|
June 1984 |
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
|
journal
|
August 1988 |
Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry
|
journal
|
January 1993 |
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
|
journal
|
November 1998 |
Pharmacokinetics and acute toxicology of intraventricular 131I-monoclonal antibody targeting disialoganglioside in non-human primates
|
journal
|
January 1997 |
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein
|
journal
|
February 1996 |
Use of Reverse Transcriptase Polymerase Chain Reaction for Diagnosis and Staging of Alveolar Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, and Desmoplastic Small Round Cell Tumor
|
journal
|
January 2001 |
An alternating selection strategy for cloning phage display antibodies
|
journal
|
August 1999 |
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
|
journal
|
January 1993 |
Selection of scFv Phages on Intact Cells Under Low pH Conditions Leads to a Significant Loss of Insert-Free Phages
|
journal
|
February 2001 |
Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique.
|
journal
|
May 1998 |
Biotechnological and gene therapeutic strategies in cancer treatment
|
journal
|
June 1995 |
High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.
|
journal
|
August 1995 |
Comparison of three different methods for radiolabelling human activated T lymphocytes
|
journal
|
May 1997 |
131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study
|
journal
|
January 1999 |
Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
|
journal
|
August 1998 |
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
|
journal
|
January 1993 |
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations
|
journal
|
April 1997 |
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
|
journal
|
November 1999 |
Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells
|
journal
|
March 1995 |
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
|
journal
|
January 2002 |
Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
|
journal
|
August 1998 |
Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement
|
journal
|
February 1999 |
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
|
journal
|
April 1988 |
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain
|
journal
|
July 1993 |
Targeting Tumor Specific Translocations in Sarcomas in Pediatric Patients for Immunotherapy
|
journal
|
January 2000 |
Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
|
journal
|
August 1999 |
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
|
journal
|
May 1993 |
Expression of CD44 splice variants in human primary brain tumors
|
journal
|
December 1995 |
In vivo tracking of tumor-specific T cells
|
journal
|
April 2001 |
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
|
journal
|
August 1970 |
Physical barriers to drug delivery in tumors
|
journal
|
February 1993 |
Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A
|
journal
|
October 1986 |
Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes.
|
journal
|
September 1993 |
Comparison of purity and enrichment of CD34 + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems
|
journal
|
January 1995 |
Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy: Quantitative imaging of I-124
|
journal
|
May 1991 |
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma
|
journal
|
May 1993 |
Ewing Family Tumors: Potential Prognostic Value of Reverse-Transcriptase Polymerase Chain Reaction Detection of Minimal Residual Disease in Peripheral Blood Samples
|
journal
|
January 1998 |
Radioimmunotherapy: recent results and future directions.
|
journal
|
April 1996 |
Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92
|
journal
|
August 2001 |
Radioimmunotargeting of Human Rhabdomyosarcoma Using Monoclonal Antibody 8H9
|
journal
|
October 2005 |
Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
|
journal
|
November 1986 |
Intra-abdominal Desmoplastic Small Round-Cell Tumor: Report of 19 Cases of a Distinctive Type of High-Grade Polyphenotypic Malignancy Affecting Young Individuals
|
journal
|
January 1991 |
A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2
|
journal
|
May 1991 |
Adoptive cellular immunotherapy for EBV lymphoproliferative diseases
|
journal
|
June 1997 |
Intraparenchymal and Intratumoral Interstitial Infusion of Anti-Glioma Monoclonal Antibody 8h9
|
journal
|
December 2008 |
Functional expression of chimeric receptor genes in human T cells
|
journal
|
February 2001 |
Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
|
journal
|
February 1999 |
Making Antibodies by Phage Display Technology
|
journal
|
April 1994 |
Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT
|
journal
|
February 1999 |
Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity
|
journal
|
March 1992 |
Cloning of the Human Sodium Iodide Symporter
|
journal
|
September 1996 |
Human Antibodies from Combinatorial Libraries
|
book
|
January 1994 |
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
|
journal
|
December 1999 |
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
|
journal
|
May 1992 |
Intergroup Rhabdomyosarcoma Study: Update for Pathologists
|
journal
|
November 1998 |
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses
|
journal
|
January 1996 |
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.
|
journal
|
June 1998 |
Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas
|
journal
|
January 2000 |
Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
|
journal
|
August 1997 |
Immunohistochemical Profile of Monoclonal Antibody 013: Antibody That Recognizes Glycoprotein p30/32MIC2 and is Useful in Diagnosing Ewingʼs Sarcoma and Peripheral Neuroepithelioma
|
journal
|
January 1994 |
Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice
|
journal
|
January 1995 |
Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
|
journal
|
December 1998 |
A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells
|
journal
|
October 1997 |
Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies
|
journal
|
September 1998 |
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
|
journal
|
February 1996 |
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
|
journal
|
February 1999 |
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma
|
journal
|
June 2000 |
Applications of monoclonal antibodies in clinical oncology
|
journal
|
December 1994 |
The Third Intergroup Rhabdomyosarcoma Study.
|
journal
|
March 1995 |
Novel Tumor-Associated Surface Antigen: Broad Distribution among Neuroectodermal, Mesenchymal and Epithelial Tumors, with Restricted Expression among Normal Tissues † 785
|
journal
|
April 1998 |
A humanized antibody that binds to the interleukin 2 receptor.
|
journal
|
December 1989 |
Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy
|
book
|
January 1994 |
Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
|
journal
|
November 1997 |
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
|
journal
|
November 1997 |
Occurrence of ganglioside GD3 in neoplastic astrocytes
|
journal
|
March 1999 |
Production and characterization of human monoclonal anti-idiotype antibodies to anti-dsDNA antibodies
|
journal
|
June 2002 |
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
|
journal
|
May 1996 |
A new class of antigen-specific killer cells
|
journal
|
January 1997 |
Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma
|
journal
|
January 1996 |
Monoclonal antibody-based therapy for neuroblastoma
|
journal
|
December 2000 |
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
|
journal
|
August 1993 |